Volitionrx (VNRX) Return on Capital Employed Growth (1y) (2022 - 2025)
Volitionrx (VNRX) Return on Capital Employed Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 125.00 |
| 10 | Volitionrx | 90,531.00 | -1.03 Mn | - | 122,305.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,305.00 |
| Sep 30, 2025 | 41,813.00 |
| Jun 30, 2025 | 351,194.00 |
| Mar 31, 2025 | -397,157.00 |
| Dec 31, 2024 | -57,565.00 |
| Sep 30, 2024 | 85,732.00 |
| Jun 30, 2024 | 108,757.00 |
| Mar 31, 2024 | 401,196.00 |
| Dec 31, 2023 | 66,986.00 |
| Sep 30, 2023 | -21,092.00 |
| Jun 30, 2023 | -56,380.00 |
| Mar 31, 2023 | -331,118.00 |
| Dec 31, 2022 | -79,851.00 |
| Sep 30, 2022 | -37,998.00 |